Kimberly-Clark Corporation (NASDAQ: KMB) is acquiring Kenvue, Johnson & Johnson’s old over-the-counter business, for nearly $49 billion. This deal includes popular brands like Tylenol and Band-Aids. Despite risks, Cramer finds Kenvue stock to be compelling due to its recent drop in value.

Kimberly-Clark (NASDAQ: KMB) manufactures personal care products like diapers, wipes, and household paper goods. Known for brands like Huggies and Kleenex, the company offers a range of consumer essentials. Investors see potential in KMB, but some suggest exploring other AI stocks for better returns.

For those seeking investment opportunities beyond Kimberly-Clark, consider exploring AI stocks with higher growth potential and lower risk. A free report on the best short-term AI stock highlights a promising investment option. Diversifying investments to include undervalued stocks can lead to significant returns in the future.

Read more at Barchart: Jim Cramer Dissects Kimberly-Clark’s Acquisition of Kenvue